• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌少性肥胖:综述

Sarcopenic obesity: a review.

作者信息

Borba Victoria Zeghbi Cochenski, Costa Tatiana Munhoz da Rocha Lemos

机构信息

Serviço de Endocrinologia e Metabologia do Hospital de Clínicas da Universidade Federal do Paraná - SEMPR, Curitiba, PR, Brasil.

出版信息

Arch Endocrinol Metab. 2025 Apr 11;68:e240084. doi: 10.20945/2359-4292-2024-0084.

DOI:10.20945/2359-4292-2024-0084
PMID:40215288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11967173/
Abstract

The global increase in life expectancy has led to a concomitant rise in diagnoses of sarcopenia. At the same time, the epidemic levels of obesity have given rise to the emergence of a complex condition known as sarcopenic obesity. Characterized by the simultaneous presence of loss of muscle mass and strength along with obesity or excess body fat, sarcopenic obesity represents a concerning health condition. Contrary to prevailing assumptions, sarcopenic obesity is not exclusive to older adults, as it may also manifest in individuals with obesity and chronic diseases and in those who undergo rapid weight loss. This juxtaposition of fat accumulation and muscle depletion epitomizes a harmful combination, especially in healthy adults. A precise definition of sarcopenic obesity and an understanding of how different body composition components affect functional parameters, comorbidities, and mortality rates are crucial for grasping the full extent and significance of this condition. Despite its multifaceted nature, sarcopenic obesity is often undiagnosed and undertreated, posing a considerable challenge to healthcare systems worldwide. In this review, we explore the intricate interplay of factors contributing to the development and consequences of sarcopenic obesity and discuss newly proposed diagnostic guidelines aimed at improved screening. Enhancing awareness and understanding of sarcopenic obesity is imperative for addressing its growing prevalence and mitigating its adverse health effects.

摘要

全球预期寿命的增加导致肌肉减少症的诊断率随之上升。与此同时,肥胖的流行程度引发了一种名为“肌少症性肥胖”的复杂病症的出现。肌少症性肥胖的特征是肌肉质量和力量同时丧失,以及肥胖或体脂过多,它代表了一种令人担忧的健康状况。与普遍的假设相反,肌少症性肥胖并非老年人所特有,因为它也可能出现在肥胖和患有慢性疾病的个体以及那些经历快速体重减轻的人身上。脂肪堆积与肌肉消耗的这种并置体现了一种有害的组合,尤其是在健康成年人中。对肌少症性肥胖进行精确的定义,并了解不同身体成分如何影响功能参数、合并症和死亡率,对于全面理解这种病症的范围和重要性至关重要。尽管肌少症性肥胖具有多方面的性质,但它往往未被诊断和治疗不足,这给全球医疗保健系统带来了相当大的挑战。在这篇综述中,我们探讨了导致肌少症性肥胖发生和后果的各种因素之间的复杂相互作用,并讨论了旨在改进筛查的新提出的诊断指南。提高对肌少症性肥胖的认识和理解对于应对其日益增长的患病率并减轻其对健康的不利影响至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5247/11967173/2b89ca6f9b48/2359-4292-aem-68-e240084-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5247/11967173/74e61f8f5d34/2359-4292-aem-68-e240084-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5247/11967173/2b89ca6f9b48/2359-4292-aem-68-e240084-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5247/11967173/74e61f8f5d34/2359-4292-aem-68-e240084-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5247/11967173/2b89ca6f9b48/2359-4292-aem-68-e240084-g02.jpg

相似文献

1
Sarcopenic obesity: a review.肌少性肥胖:综述
Arch Endocrinol Metab. 2025 Apr 11;68:e240084. doi: 10.20945/2359-4292-2024-0084.
2
Sarcopenic obesity in older adults: a clinical overview.老年人肌少症性肥胖:临床概述。
Nat Rev Endocrinol. 2024 May;20(5):261-277. doi: 10.1038/s41574-023-00943-z. Epub 2024 Feb 6.
3
A moderate intensity exercise program improves physical function and oxidative damage in older women with and without sarcopenic obesity.一项中等强度的运动方案可改善患有和不患有肌肉减少性肥胖的老年女性的身体功能和氧化损伤。
Exp Gerontol. 2021 Jul 15;150:111360. doi: 10.1016/j.exger.2021.111360. Epub 2021 Apr 18.
4
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management.肌少症性肥胖:流行病学、病理生理学、心血管疾病、死亡率和管理。
Front Endocrinol (Lausanne). 2023 Jun 30;14:1185221. doi: 10.3389/fendo.2023.1185221. eCollection 2023.
5
Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative review.社区居住老年人的肌少性肥胖以及营养与运动综合干预——一项叙述性综述
Clin Interv Aging. 2015 Aug 6;10:1267-82. doi: 10.2147/CIA.S82454. eCollection 2015.
6
Sarcopenic obesity.肌少症性肥胖。
Hormones (Athens). 2018 Sep;17(3):321-331. doi: 10.1007/s42000-018-0049-x. Epub 2018 Jul 16.
7
Sarcopenic obesity and weight loss-induced muscle mass loss.肌少性肥胖与体重减轻引起的肌肉量减少。
Curr Opin Clin Nutr Metab Care. 2025 Jul 1;28(4):339-350. doi: 10.1097/MCO.0000000000001131. Epub 2025 Apr 29.
8
Sarcopenia and obesity.肌少症与肥胖。
Curr Opin Clin Nutr Metab Care. 2019 Jan;22(1):13-19. doi: 10.1097/MCO.0000000000000519.
9
Sarcopenic obesity: Time to meet the challenge.肌少症性肥胖:是时候迎接挑战了。
Clin Nutr. 2018 Dec;37(6 Pt A):1787-1793. doi: 10.1016/j.clnu.2018.04.018. Epub 2018 May 7.
10
Sarcopenic Obesity: An Appraisal of the Current Status of Knowledge and Management in Elderly People.肌少症性肥胖:老年人知识现状与管理评估
J Nutr Health Aging. 2016;20(7):780-8. doi: 10.1007/s12603-015-0631-8.

引用本文的文献

1
The Role of Rehabilitation Program in Managing the Triad of Sarcopenia, Obesity, and Chronic Pain.康复计划在管理肌肉减少症、肥胖症和慢性疼痛三联征中的作用。
Life (Basel). 2025 Jul 24;15(8):1174. doi: 10.3390/life15081174.

本文引用的文献

1
Applicability of the Diagnostic Criteria for Sarcopenic Obesity Defined by ESPEN/EASO Criteria in Acutely Admitted Patients with Stroke: Prevalence and Association with Outcomes.ESPEN/EASO 标准定义的肌少症性肥胖诊断标准在急性脑卒中入院患者中的适用性:患病率及与结局的相关性。
J Nutr Sci Vitaminol (Tokyo). 2023;69(6):454-462. doi: 10.3177/jnsv.69.454.
2
Obesity paradox in older sarcopenic adults - a delay in aging: A systematic review and meta-analysis.老年肌少症肥胖悖论——延缓衰老:系统评价和荟萃分析。
Ageing Res Rev. 2024 Jan;93:102164. doi: 10.1016/j.arr.2023.102164. Epub 2023 Dec 14.
3
Mitochondrial Dysfunction and Sarcopenic Obesity: The Role of Exercise.
线粒体功能障碍与肌少症性肥胖:运动的作用
J Clin Med. 2023 Aug 29;12(17):5628. doi: 10.3390/jcm12175628.
4
GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway.胰高血糖素样肽-1受体激动剂利拉鲁肽和司美格鲁肽通过SIRT1通路改善肥胖诱导的肌肉萎缩。
Diabetes Metab Syndr Obes. 2023 Aug 15;16:2433-2446. doi: 10.2147/DMSO.S425642. eCollection 2023.
5
Effect of Coenzyme Q10 Supplementation on Sarcopenia, Frailty, and Falls: A Scoping Review.辅酶 Q10 补充对肌肉减少症、虚弱和跌倒的影响:范围综述。
J Nutr Health Aging. 2023;27(7):586-592. doi: 10.1007/s12603-023-1943-8.
6
Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.肥胖老年男性的肌肉减少症患病率和功能结局:比较使用 EWGSOP2 肌肉减少症与 ESPEN-EASO 肌肉减少性肥胖共识定义。
Clin Nutr. 2023 Sep;42(9):1610-1618. doi: 10.1016/j.clnu.2023.07.014. Epub 2023 Jul 17.
7
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management.肌少症性肥胖:流行病学、病理生理学、心血管疾病、死亡率和管理。
Front Endocrinol (Lausanne). 2023 Jun 30;14:1185221. doi: 10.3389/fendo.2023.1185221. eCollection 2023.
8
Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancer.生物电阻抗分析中脂肪与肌肉质量比在接受胰腺癌手术患者长期生存中的独立作用。
Front Nutr. 2023 Jun 13;10:1118616. doi: 10.3389/fnut.2023.1118616. eCollection 2023.
9
Sarcopenic obesity: emerging mechanisms and therapeutic potential.肌少症性肥胖:新兴机制与治疗潜力。
Metabolism. 2023 Sep;146:155639. doi: 10.1016/j.metabol.2023.155639. Epub 2023 Jun 26.
10
Frequency and Functional Consequences of Low Appendicular Lean Mass and Sarcopenic Obesity in Patients with Asthma Referred for Pulmonary Rehabilitation.哮喘患者行肺康复治疗时四肢骨骼肌质量低和肌少症性肥胖的发生率及其功能后果。
Obes Facts. 2023;16(5):435-446. doi: 10.1159/000531196. Epub 2023 May 25.